AnalystsJames Shin
James Shin's Stock Forecasts

Analyst Ranking
Top 33%
#1584 out of 4906 analysts
Average Return
+11.36%
Win Rate
64%7 out of 11
Risk vs Reward
Poor
Good

James Shin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunogen IncIMGN
+111.87%$14.74$31.23
2023-11-08 -
2024-02-09
Strong Buy
Sutro Biopharma IncSTRO
+94.67%$2.25$4.38
2023-11-08 -
2024-11-08
Strong Buy
Immatics NvIMTX
+19.07%$5.14$6.12
2025-05-27 -
2025-06-13
Strong Buy
Autolus Therapeutics PLCAUTL
+6.88%$3.49$3.73
2023-11-08 -
2024-11-08
Strong Buy
Gilead Sciences IncGILD
+4.49%$105.25$109.98
2025-02-17 -
2025-06-13
Strong Buy

James Shin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Immatics NvIMTX
1Strong Buy$10.00+63.40%Initiates Coverage On
19 days ago
Gilead Sciences IncGILD
2Strong Buy$120.00+9.11%Upgrades
4 months ago
Merck & Co IncMRK
2Hold$105.00+28.50%Downgrades
4 months ago
Eli Lilly & CoLLY
4Strong Buy$1,015.00+23.88%Maintains
7 months ago
Amgen IncAMGN
2Hold$305.00+3.31%Reiterates
10 months ago
Incyte CorpINCY
2Hold$60.00-11.44%Maintains
10 months ago
Bristol Myers Squibb CoBMY
2Hold$45.00-9.55%Maintains
a year ago
Legend Biotech CorpLEGN
1Strong Buy$60.00N/AInitiates Coverage On
a year ago
Abbvie IncABBV
1Hold$150.00N/AInitiates Coverage On
2 years ago
Regeneron Pharmaceuticals IncREGN
1Hold$800.00N/AInitiates Coverage On
2 years ago
Immunogen IncIMGN
1Strong Buy$25.00N/AInitiates Coverage On
2 years ago
Autolus Therapeutics PLCAUTL
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Sutro Biopharma IncSTRO
1Strong Buy$12.00N/AInitiates Coverage On
2 years ago
Affimed NvAFMDQ
1Strong Buy$70.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.